Literature DB >> 10987092

Tat as a transcriptional activator and a potential therapeutic target for HIV-1.

A Gatignol1, K T Jeang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10987092     DOI： 10.1016/s1054-3589(00)48007-5

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  24 in total

Review 1.  Emergence of a complex relationship between HIV-1 and the microRNA pathway.

Authors:  Dominique L Ouellet; Isabelle Plante; Corinne Barat; Michel J Tremblay; Patrick Provost
Journal:  Methods Mol Biol       Date:  2009

2.  Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.

Authors:  Yan Desfosses; Mayra Solis; Qiang Sun; Nathalie Grandvaux; Carine Van Lint; Arsene Burny; Anne Gatignol; Mark A Wainberg; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.

Authors:  Xuechao Zhao; Lingyu Qian; Deyu Zhou; Di Qi; Chang Liu; Xiaohong Kong
Journal:  Virol Sin       Date:  2016-03-21       Impact factor: 4.327

4.  HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.

Authors:  Slava Rom; Marco Pacifici; Giovanni Passiatore; Susanna Aprea; Agnieszka Waligorska; Luis Del Valle; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2011-07-01

5.  Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

Review 6.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

7.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

8.  Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells.

Authors:  Olivier Rohr; Dominique Lecestre; Sylvette Chasserot-Golaz; Céline Marban; Dorina Avram; Dominique Aunis; Mark Leid; Evelyne Schaeffer
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.

Authors:  Sarah J Bertrand; Marina V Aksenova; Charles F Mactutus; Rosemarie M Booze
Journal:  Exp Neurol       Date:  2013-06-26       Impact factor: 5.330

10.  The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production.

Authors:  María Rosa López-Huertas; Elena Mateos; María Sánchez Del Cojo; Francisco Gómez-Esquer; Gema Díaz-Gil; Sara Rodríguez-Mora; Juan Antonio López; Enrique Calvo; Guillermo López-Campos; José Alcamí; Mayte Coiras
Journal:  J Biol Chem       Date:  2013-01-30       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.